BNP Paribas Financial Markets’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $923K | Buy |
49,531
+48,173
| +3,547% | +$897K | ﹤0.01% | 2249 |
|
|
2025
Q1 | $24.6K | Sell |
1,358
-1,337
| -50% | -$24.3K | ﹤0.01% | 3643 |
|
|
2024
Q4 | $58.8K | Buy |
+2,695
| New | +$58.8K | ﹤0.01% | 3509 |
|
|
2023
Q3 | – | Sell |
-280
| Closed | -$3.39K | – | 3253 |
|
|
2023
Q2 | $3.39K | Sell |
280
-25
| -8% | -$303 | ﹤0.01% | 3071 |
|
|
2023
Q1 | $3.88K | Sell |
305
-53
| -15% | -$674 | ﹤0.01% | 2969 |
|
|
2022
Q4 | $2.27K | Buy |
358
+34
| +10% | +$215 | ﹤0.01% | 3065 |
|
|
2022
Q3 | $7.32K | Sell |
324
-1,416
| -81% | -$32K | ﹤0.01% | 3497 |
|
|
2022
Q2 | $33.4K | Buy |
1,740
+1,449
| +498% | +$27.8K | ﹤0.01% | 3003 |
|
|
2022
Q1 | $13.5K | Sell |
291
-124
| -30% | -$5.76K | ﹤0.01% | 3193 |
|
|
2021
Q4 | $29.4K | Buy |
415
+73
| +21% | +$5.17K | ﹤0.01% | 3170 |
|
|
2021
Q3 | $39.8K | Buy |
342
+278
| +434% | +$32.4K | ﹤0.01% | 2969 |
|
|
2021
Q2 | $9.98K | Sell |
64
-137
| -68% | -$21.4K | ﹤0.01% | 3128 |
|
|
2021
Q1 | $38.1K | Sell |
201
-38
| -16% | -$7.21K | ﹤0.01% | 3102 |
|
|
2020
Q4 | $30K | Sell |
239
-65
| -21% | -$8.15K | ﹤0.01% | 3101 |
|
|
2020
Q3 | $33.1K | Buy |
304
+263
| +641% | +$28.6K | ﹤0.01% | 3024 |
|
|
2020
Q2 | $4.93K | Sell |
41
-332
| -89% | -$39.9K | ﹤0.01% | 3381 |
|
|
2020
Q1 | $37.5K | Buy |
373
+231
| +163% | +$23.2K | ﹤0.01% | 3071 |
|
|
2019
Q4 | $34.3K | Sell |
142
-19
| -12% | -$4.59K | ﹤0.01% | 3174 |
|
|
2019
Q3 | $26.4K | Buy |
161
+60
| +59% | +$9.83K | ﹤0.01% | 3185 |
|
|
2019
Q2 | $23.9K | Sell |
101
-87
| -46% | -$20.6K | ﹤0.01% | 3210 |
|
|
2019
Q1 | $49.6K | Buy |
+188
| New | +$49.6K | ﹤0.01% | 2909 |
|